Lanean...
Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments
Although adverse effects and glucocorticoid resistance cripple their chronic use, glucocorticoids form the mainstay therapy for acute and chronic inflammatory disorders, and play an important role in treatment protocols of both lymphoid malignancies and as adjuvant to stimulate therapy tolerability...
Gorde:
| Argitaratua izan da: | Oncoscience |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Impact Journals LLC
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5043069/ https://ncbi.nlm.nih.gov/pubmed/27713909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncoscience.315 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|